Respiratory challenges after organ transplant encompass a range of complications that affect lung function and patient outcomes. Recipients of solid organ transplants, particularly heart and lung transplants, are susceptible to infections, acute and chronic rejection, airway obstruction, and drug-related pulmonary toxicity. Early detection of respiratory issues is critical, as symptoms such as shortness of breath, cough, or hypoxemia may signal serious complications. Diagnostic evaluation includes pulmonary function testing, imaging, bronchoscopy, and microbiological assessment to distinguish infectious, inflammatory, or mechanical causes.
Management requires an individualized approach balancing immunosuppression, infection control, and supportive care. Prompt antimicrobial therapy, adjustment of immunosuppressive regimens, and interventions for airway complications are essential. Pulmonary rehabilitation, oxygen therapy, and close monitoring of lung function help maintain long-term respiratory health. Multidisciplinary collaboration among transplant surgeons, pulmonologists, infectious disease specialists, and critical care teams ensures comprehensive care. Education of patients and caregivers on early recognition of symptoms, adherence to therapy, and lifestyle modifications further enhances outcomes. Effective management of respiratory challenges after organ transplant is critical to preserve graft function, optimize quality of life, and prevent long-term complications.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation